These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36653538)

  • 1. Lay etiology concepts of cancer patients do not correlate with their usage of complementary and/or alternative medicine.
    Huebner J; Muecke R; Micke O; Prott FJ; Josfeld L; Büntzel J; Büntzel J;
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6067-6074. PubMed ID: 36653538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The experiences of persons living with HIV who participate in mind-body and energy therapies: a systematic review protocol of qualitative evidence.
    Bremner M; Blake B; Stiles C
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):41-9. PubMed ID: 26571281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-efficacy in relation to the use of complementary and alternative medicine, lifestyle choices and cancer aetiology.
    Josfeld L; Krüger L; Büntzel J; Zomorodbakhsch B; Hübner J
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2707-2715. PubMed ID: 34812932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
    Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
    JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care.
    Wortmann JK; Bremer A; Eich HT; Wortmann HP; Schuster A; Fühner J; Büntzel J; Muecke R; Prott FJ; Huebner J
    Med Oncol; 2016 Jul; 33(7):78. PubMed ID: 27300549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traits of cancer patients and CAM usage.
    Dufter SA; Hübner J; Ahmadi E; Zomorodbakhsch B
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3685-3692. PubMed ID: 33811274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary and alternative medicine: use and disclosure in radiation oncology community practice.
    Rausch SM; Winegardner F; Kruk KM; Phatak V; Wahner-Roedler DL; Bauer B; Vincent A
    Support Care Cancer; 2011 Apr; 19(4):521-9. PubMed ID: 20336329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdisciplinary Integrative Oncology Group-Based Program: Evaluation of Long-Term Effects on Resilience and Use of Complementary and Alternative Medicine in Patients With Cancer.
    Von Reusner MJ; Märtens B; Barthel S; Weiser A; Ziert Y; Steinmann D; Babadağ-Savaş B
    Integr Cancer Ther; 2024; 23():15347354241269931. PubMed ID: 39155547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany.
    Kessel KA; Lettner S; Kessel C; Bier H; Biedermann T; Friess H; Herrschbach P; Gschwend JE; Meyer B; Peschel C; Schmid R; Schwaiger M; Wolff KD; Combs SE
    PLoS One; 2016; 11(11):e0165801. PubMed ID: 27812163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Online survey of cancer patients on complementary and alternative medicine.
    Huebner J; Prott FJ; Micke O; Muecke R; Senf B; Dennert G; Muenstedt K;
    Oncol Res Treat; 2014; 37(6):304-8. PubMed ID: 24903760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge about complementary, alternative and integrative medicine (CAM) among registered health care providers in Swedish surgical care: a national survey among university hospitals.
    Bjerså K; Stener Victorin E; Fagevik Olsén M
    BMC Complement Altern Med; 2012 Apr; 12():42. PubMed ID: 22498305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study.
    Podlecka-Piętowska A; Sugalska M; Janiszewska K; Wall-Szczech A; Cyganek A; Szejko N; Zakrzewska-Pniewska B
    Neurol Neurochir Pol; 2022; 56(5):428-434. PubMed ID: 36069151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient activation, self-efficacy and usage of complementary and alternative medicine in cancer patients.
    Hübner J; Welter S; Ciarlo G; Käsmann L; Ahmadi E; Keinki C
    Med Oncol; 2022 Sep; 39(12):192. PubMed ID: 36071252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and determinants of complementary medicine use for nigerian children in the Turkish Republic of Northern Cyprus.
    Christopher GO; Ozturk C
    Niger J Clin Pract; 2020 Aug; 23(8):1054-1060. PubMed ID: 32788481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative approaches to epilepsy treatment.
    McElroy-Cox C
    Curr Neurol Neurosci Rep; 2009 Jul; 9(4):313-8. PubMed ID: 19515284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment.
    Wolf CPJG; Rachow T; Ernst T; Hochhaus A; Zomorodbakhsch B; Foller S; Rengsberger M; Hartmann M; Huebner J
    J Cancer Res Clin Oncol; 2022 May; 148(5):1123-1135. PubMed ID: 34228225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary and alternative medicine usage in Scottish children and adolescents during cancer treatment.
    Revuelta-Iniesta R; Wilson ML; White K; Stewart L; McKenzie JM; Wilson DC
    Complement Ther Clin Pract; 2014 Nov; 20(4):197-202. PubMed ID: 25087468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience.
    Naing A; Stephen SK; Frenkel M; Chandhasin C; Hong DS; Lei X; Falchook G; Wheler JJ; Fu S; Kurzrock R
    Cancer; 2011 Nov; 117(22):5142-50. PubMed ID: 21538342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and Alternative Medicine Use at a Comprehensive Cancer Center.
    Luo Q; Asher GN
    Integr Cancer Ther; 2017 Mar; 16(1):104-109. PubMed ID: 27151586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.